University of Texas MD Anderson Cancer Center-ko ikertzaileekin lankidetzan egindako argitalpenak (21)

2024

  1. Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists

    Histopathology, Vol. 84, Núm. 3, pp. 429-439

2023

  1. Sperm protein antigen 17 and Sperm flagellar 1 cancer testis antigens are expressed in a rare case of ciliated foregut cyst of the common hepatic duct

    Pathology Research and Practice, Vol. 247

2022

  1. NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma

    Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 793-805

  2. Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee

    Journal of Thoracic Oncology, Vol. 17, Núm. 12, pp. 1335-1354

2021

  1. The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC

    Journal of Thoracic Oncology, Vol. 16, Núm. 4, pp. 686-696

2020

  1. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

    Journal of Thoracic Oncology, Vol. 15, Núm. 10, pp. 1599-1610

  2. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

    Journal of Thoracic Oncology, Vol. 15, Núm. 5, pp. 709-740

  3. PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

    Journal of Thoracic Oncology, Vol. 15, Núm. 4, pp. 499-519

  4. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

    Journal of Thoracic Oncology, Vol. 15, Núm. 9, pp. 1409-1424

2019

  1. Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer

    Journal of Thoracic Oncology, Vol. 14, Núm. 3, pp. 377-407

2017

  1. Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets

    Oncotarget, Vol. 8, Núm. 67, pp. 111386-111395

2016

  1. Imaging mass spectrometry assists in the classification of diagnostically challenging atypical Spitzoid neoplasms

    Journal of the American Academy of Dermatology, Vol. 75, Núm. 6, pp. 1176-1186.e4

2015

  1. Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model

    Journal of Clinical Oncology, Vol. 33, Núm. 32, pp. 3766-3773

  2. PET-Florbetapir findings in primary cerebral amyloidoma

    Journal of Neurology

2013

  1. MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma

    British Journal of Haematology, Vol. 162, Núm. 3, pp. 336-347

1994

  1. Open quiz solution: Case report 806

    Skeletal Radiology, Vol. 23, Núm. 1, pp. 55-57

1993

  1. Case report 806

    Skeletal Radiology, Vol. 22, Núm. 6, pp. 476

  2. Open quiz: Case report 806

    Skeletal Radiology, Vol. 22, Núm. 6, pp. 476

1992

  1. Neurothekeoma of the oral cavity: Case report and review of the literature

    Journal of Oral and Maxillofacial Surgery, Vol. 50, Núm. 11, pp. 1224-1226

  2. Synovial sarcoma of the tongue: Case report and review of the literature

    Journal of Oral and Maxillofacial Surgery, Vol. 50, Núm. 8, pp. 904-906